United States News Todas as matérias

BankUnited (NYSE:BKU) reported first-quarter 2026 net income of $62 million, or $0.83 per diluted share.

Fidelity D & D Bancorp (NASDAQ:FDBC), the parent company of The Fidelity Deposit and Discount Bank, delivered a strong start to 2026, reporting net income of $7.5 million for the quarter ended March 31, 2026.

Civista Bancshares (NASDAQ:CIVB) reported a substantial increase in profitability for the first quarter of 2026, marking its first full quarter of operations following the acquisition of FSB, which closed on November 7, 2025.

Old National Bancorp (NASDAQ:ONB) reported first-quarter 2026 net income applicable to common shares of $229.6 million, or $0.59 per diluted share.

Boost Run (NASDAQ:WLAC), an AI cloud infrastructure provider currently in the process of merging with Willow Lane Acquisition (NASDAQ:WLAC), announced a definitive $1.44 billion purchase agreement with Dell Technologies (NYSE:DELL) today.

RenX Enterprises (NASDAQ:RENX) announced today that it expects to report consolidated revenue in excess of $3.5 million for the first quarter of 2026.

Travel + Leisure Company (NYSE:TNL) revealed robust financial results for the first quarter of 2026, driven by sustained demand for leisure travel and increased efficiency in its vacation ownership business.

Stifel Financial (NYSE:SF) delivered a powerful start to 2026, reporting record first-quarter net revenues of $1.48 billion.

CME Group (NASDAQ:CME) delivered record-breaking financial results for the first quarter of 2026, fueled by an all-time high in trading activity across its global derivatives marketplace.

Masco (NYSE:MAS), a global leader in home improvement and building products, reported a robust start to 2026, characterized by high single-digit growth in its plumbing division and a significant expansion of its capital return program.

Stock Yards Bancorp (NASDAQ:SYBT), the parent company of Stock Yards Bank & Trust Company, reported record financial results for the first quarter of 2026.

The Boeing Company (NYSE:BA) reported first-quarter 2026 revenue of $22.2 billion, reflecting a period of high production demand tempered by ongoing supply chain stabilization and heavy capital investment.

KeyCorp (NYSE:KEY) has reached a definitive agreement to acquire Clearwater Corporate Finance (Clearwater UK), a move that signals a bold international expansion for the Cleveland-based financial services firm.

Spire (NYSE:SR) announced a strategic divestiture of its Mississippi local distribution company to Delta Utilities for a total purchase price of $75 million.

Philip Morris International (NYSE:PM) reported robust financial results for the first quarter of 2026, highlighted by the continued aggressive expansion of its smoke-free portfolio.

Otis Worldwide (NYSE:OTIS) delivered a resilient first-quarter performance for 2026, reporting net sales of $3.6 billion.

Boston Scientific (NYSE:BSX) delivered a strong start to 2026, reporting first-quarter net sales of $5.203 billion.

AT&T (NYSE:T) delivered a steady start to 2026, reporting first-quarter consolidated revenues of $31.5 billion.

Amneal Pharmaceuticals (NASDAQ:AMRX) and Kashiv BioSciences announced today that they have entered into a definitive agreement for Amneal to acquire Kashiv.

Elevance Health (NYSE:ELV) reported first-quarter 2026 results that surpassed analyst estimates, driven by strong operational execution in its Carelon segment and improved premium yields.

Cboe Global Markets (CBOE) has entered into a definitive agreement to sell its Australian and Canadian exchange operations to TMX Group for an aggregate purchase price of $300 million.

TE Connectivity (NYSE:TEL) delivered a record-breaking performance for its fiscal second quarter ended March 27, 2026, as the global demand for high-speed data transmission and automotive electrification reached new heights.

Vertiv Holdings (NYSE:VRT), a global leader in critical digital infrastructure, delivered a powerful set of first-quarter results that exceeded market expectations, driven by the accelerating demand for high-density AI computing.

Hengrui Pharmaceuticals delivered a high-growth start to 2026, underscored by a deepening shift toward its innovative drug portfolio and a successful entry into the U.S. capital markets.